Opportunities in the hemato-oncology testing market include rising lymphoma and myeloma cases, personalized therapy demand, and advanced molecular diagnostics. Emerging technologies like single-cell ...

PE: Is collecting RWD more complicated in today’s world? Nasser: Techniques like data federation start to reduce the burden and activation energy of collecting data. If we were trying to centralize ...

Software and data analytics are creating a new landscape for investors in medicine. Genomics stands at the forefront of this ...

SeqOne, a pioneer in AI-driven genomic analysis, today announced it has entered into a definitive agreement to acquire ...

RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT ...

In rare disease, the European long-read innovation network, advanced delivery of its 10,000 genome program over 3 years, working to a transition from short-read sequencing to Oxford Nanopore's ...

According to Vantage Market Research, the cancer diagnostics market is witnessing rapid growth driven by rising global cancer ...

Powered by proprietary single-molecule next-generation sequencing (smNGS) technology, Northstar Select sets a new standard in sensitivity for non-invasive, blood-based comprehensive genomic profiling ...

Prostate cancer is one of the leading causes of cancer-related death in men. Most patients who are diagnosed during earlier stages usually respond well to treatment. In some, however, the disease ...

What Web3 needs now is a clean break from legacy limitations. The next generation of chains must be built for speed from day one. This includes advanced sequencing architectures that allow networks to ...

Moderna, Inc. (NASDAQ:MRNA) stands fifth among the best cancer stocks. It is best known for its mRNA COVID-19 vaccine and is expanding into oncology with a focus on personalized cancer immunotherapies ...

Researchers from The University of Osaka develop a new nanotechnology that efficiently unzips DNA for quick and easy genetic ...